Recent Advances with Liposomes as Drug Carriers - Advanced Biomaterials and Biodevices - page 117

258. Latimer, P., et al. , Aerosol delivery of liposomal formulated paclitaxel and
vitamin E analog reduces murine mammary tumor burden and metastases.
Exp Biol Med (Maywood) , 2009. 234(10): p. 1244-52.
259. Patel, N.R., et al. , Reversal of multidrug resistance by co-delivery of tariqui-
dar (XR9576) and paclitaxel using long-circulating liposomes. Int J Pharm ,
2011. 416(1): p. 296-9.
260. Liang, G.W., et al. , Enhanced therapeutic ef ects on the multi-drug resistant
human leukemia cells in vitro and xenograt in mice using the stealthy lipo-
somal vincristine plus quinacrine. Fundam Clin Pharmacol , 2008. 22(4): p.
429-37.
261. Raju, A., M.S. Muthu, and S.S. Feng, Trastuzumab-conjugated vitamin E
TPGS liposomes for sustained and targeted delivery of docetaxel. Expert
Opin Drug Deliv , 2013. 10(6): p. 747-60.
262. Chen, Y., et al. , Multifunctional nanoparticles delivering small interfering
RNA and doxorubicin overcome drug resistance in cancer. J Biol Chem ,
2010. 285(29): p. 22639-50.
263. Wang, H., et al. , PLGA/polymeric liposome for targeted drug and gene co-
delivery. Biomaterials , 2010. 31(33): p. 8741-8.
264. Xiao, W., et al. , Co-delivery of doxorubicin and plasmid by a novel FGFR-
mediated cationic liposome. Int J Pharm , 2010. 393(1-2): p. 119-26.
265. Pastorino, F., et al. , Increase of therapeutic ef ects by treating melanoma
with targeted combinations of c-myc antisense and doxorubicin. J Control
Release , 2008. 126(1): p. 85-94.
266. Guo, L., et al. , TRAIL and doxorubicin combination enhances anti-glioblas-
toma ef ect based on passive tumor targeting of liposomes. J Control Release ,
2011. 154(1): p. 93-102.
267. Sun, X., et al. , Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma
mediated by an angiopep-conjugated liposome. Biomaterials , 2012. 33(3): p.
916-24.
268. Sawant, R.R., et al. , Palmitoyl ascorbate-modii ed liposomes as nanoparticle
platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery. Eur
J Pharm Biopharm , 2010. 75(3): p. 321-6.
269. Sawant, R.R., et al. , Palmitoyl ascorbate liposomes and free ascorbic acid:
comparison of anticancer therapeutic ef ects upon parenteral administra-
tion. Pharm Res , 2012. 29(2): p. 375-83.
270. Zhu, L. and V.P. Torchilin, Stimulus-responsive nanopreparations for tumor
targeting. Integrative Biology , 2013. 5(1): p. 96-107.
271. Preiss, M.R. and G.D. Bothun, Stimuli-responsive liposome-nanoparticle
assemblies. Expert Opin Drug Deliv , 2011. 8(8): p. 1025-1040.
272. Zhang, X.-X., H.S. Eden, and X. Chen, Peptides in cancer Nanomedicine :
drug carriers, targeting ligands and protease substrates. Journal of Controlled
Release , 2012. 159(1): p. 2-13.
273. Kaasgaard, T. and T.L. Andresen, Liposomal cancer therapy: exploiting
tumor characteristics. Expert Opin Drug Deliv , 2010. 7(2): p. 225-243.